1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Malignant Peripheral Nerve Sheath Tumors (MPNST): new trials by email Literature Review of Malignant Peripheral Nerve Sheath Tumors (MPNST) trials Research Report on Malignant Peripheral Nerve Sheath Tumors (MPNST)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) ASTX727 - Malignant Peripheral Nerve Sheath Tumors (MPNST) | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 25 | 2021-04-29 | 2026-02-05 |
| A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors Phase 1b: APG-115+pembrolizumab - Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma | Phase 1 / Phase 2 | Active not recruiting | Ascentage Pharma Group Inc. | 230 | 2018-08-29 | 2025-08-07 |
| SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) ganetespib, Sirolimus - Malignant Peripheral Nerve Sheath Tumors (MPNST), Sarcoma | Phase 1 / Phase 2 | Completed | Sarcoma Alliance for Research through Collaboration | 20 | 2013-12-01 | 2019-05-15 |
Neurofibrosarcoma (3) · Melanoma (1) · Sarcoma (1) · Uveal Melanoma (1)
Fibrosarcoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3) · Neoplasms, Nerve Tissue (3) · Nerve Sheath Neoplasms (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Neurofibroma (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (3) · Peripheral Nervous System Neoplasms (3) · Sarcoma (2)
STA 9090 (1) · Sirolimus (1) · decitabine and cedazuridine drug combination (1) · pembrolizumab (1)
Ascentage Pharma Group Inc. (1) · Memorial Sloan Kettering Cancer Center (1) · Sarcoma Alliance for Research through Collaboration (1)
United States (3) · Australia (1)
AeRang Kim, MD, PhD (1) · Brigitte Widemann, MD (1) · Ping Chi, MD, PhD (1) · Yifan Zhai, MD, PhD (1)